Displaying drugs 2326 - 2350 of 2797 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Chlorthalidone | 338.766 C14H11ClN2O4S |  | A diuretic used to treat hypertension or edema caused by heart failure, renal failure, hepatic cirrhosis, estrogen therapy, and other conditions. | Low-Ceiling Diuretics and Potassium-Sparing Agents / Sulfonamides |
| Procyclidine | 287.4397 C19H29NO |  | An antispasmodic drug used to treat parkinsonism of various types and in the treatment of extrapyramidal symptoms. | Tertiary Amines |
| Cycrimine | 287.4397 C19H29NO |  | For treatment and management of Parkinson's disease. | Agents producing tachycardia |
| Methsuximide | 203.2371 C12H13NO2 |  | A succinimide anticonvulsant that increases the seizure threshold. Primarily used for childhood absence seizures. Functions by suppressing paroxysmal spike-and-wave patterns associated with lapses of consciousness in absence seizures. | Succinimide Derivatives |
| Isoaminile | 244.382 C16H24N2 |  | Isoaminile, an antitussive drug with a structure similar to methadone, is also an anticholinergic with both antimuscarinic and antinicotinic properties. | Antitussive Agents |
| Ethosuximide | 141.1677 C7H11NO2 |  | An anticonvulsant used to treat petit mal seizures. | Succinimide Derivatives |
| Tromethamine | 121.135 C4H11NO3 |  | A proton acceptor used for the prevention and correction of metabolic acidosis associated with various clinical conditions, such as cardiac bypass surgery. | Solutions Affecting the Electrolyte Balance |
| Citric acid | 192.1235 C6H8O7 |  | An anti-chelation additive used in blood collection tubes and as a flavoring and preservative agent in various cosmetic and pharmaceutical products. | Acid Preparations |
| Chlorisondamine | 358.13 C14H20Cl4N2 |  | Not Annotated | Antihypertensive Agents / Ganglion Blockers / Nicotinic Antagonists |
| Ferric chloride | 162.204 Cl3Fe |  | Not Annotated | Caustics / Noxae |
| Gadobutrol | 604.72 C18H31GdN4O9 |  | A gadolinium-based contrast agent (GBCA) used with contrasted magnetic resonance imaging (MRI) to detect and visualize lesions and abnormal vascularity. | Paramagnetic Contrast Media |
| Ferrous sulfate anhydrous | 151.908 FeO4S |  | An iron supplement used to prevent or treat iron deficiency anemia. | Anemia, Iron-Deficiency / Delayed-Action Preparations / Hematinics |
| Hydrogen peroxide | 34.0147 H2O2 |  | A compound used as a disinfectant and sterilizer. | Antiinfectives and Antiseptics for Local Oral Treatment |
| Phosphorus | 30.9738 P |  | A medication indicated in the treatment of hypophosphatemia. | Elements |
| Nitrogen | 28.0134 N2 |  | A cryogenic agent used to treat various benign and malignant skin lesions. | Medical Gases |
| Barium sulfate | 233.39 BaO4S |  | A contrast agent used for CT scans of the gastrointestinal tract. | Barium Sulfate Containing X-Ray Contrast Media |
| Chloroxine | 214.048 C9H5Cl2NO |  | An antibacterial agent used for the treatment of dandruff and mild to moderately severe seborrheic dermatitis of the scalp. | Anti-Bacterial Agents / Antifungal Agents |
| Water | 18.0153 H2O |  | A naturally-occurring element used as an ingredient and vehicle in various pharmaceutical preparations of water. | Diluents / EENT Drugs, Miscellaneous / Irrigating Solutions / Other Miscellaneous Therapeutic Agents / Oxygen Compounds |
| Estradiol dienanthate | 496.732 C32H48O4 |  | An estrogen used in some combined hormonal oral contraceptives. | BCRP/ABCG2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP1A2 Inhibitors (weak) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2C19 Substrates / Cytochrome P-450 CYP2C8 Substrates / Cytochrome P-450 CYP2C9 Substrates / Cytochrome P-450 CYP3A Inducers / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Inducers / Cytochrome P-450 CYP3A4 Inducers (strength unknown) / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 CYP3A7 Substrates / Cytochrome P-450 Enzyme Inducers / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Estradiol Congeners / Estranes / Estrenes / Fused-Ring Compounds / Gonadal Hormones / Gonadal Steroid Hormones / Hormones / Hormones, Hormone Substitutes, and Hormone Antagonists / OATP1B1/SLCO1B1 Inhibitors / OCT1 inhibitors / OCT2 Inhibitors / Organic Anion Transporting Polypeptide 2B1 Inhibitors / P-glycoprotein substrates / Steroids / UGT1A1 Substrates |
| Zinc sulfate | 161.472 O4SZn |  | A drug used to replenish low levels of zinc or prevent zinc deficiency, or to test for zinc deficiency. | Electrolyte Solutions / Zinc Compounds |
| Acamprosate | 181.21 C5H11NO4S |  | A medication used to maintain alcohol abstinence in patients with alcohol dependence. | Alcohol Deterrents / Drugs Used in Alcohol Dependence |
| Ataluren | 284.242 C15H9FN2O3 |  | A medication used for the treatment of Duchenne muscular dystrophy. | Musculo-Skeletal System / OAT1/SLC22A6 inhibitors / OAT3/SLC22A8 Inhibitors / OATP1B3 inhibitors / Oxazoles / UGT1A9 Substrates |
| Potassium nitrate | 101.1032 KNO3 |  | A medication used to cauterize small wounds, remove granulation tissue, warts, and verrucae, and treat tooth sensitivity. | Explosive Agents / Potassium Salt |
| Sodium sulfate | 142.042 Na2O4S |  | An agent used for bowel cleansing prior to colonoscopy or barium enema X-ray examination. | Laxatives / Sodium |
| Dipotassium phosphate | 174.1759 HK2O4P |  | An ionic compound used for electrolyte replenishment and total parenteral nutrition (TPN) therapy. | Buffers / Cariostatic Agents / Dental Materials / Laxatives / Potassium Salt |
Displaying drugs 2326 - 2350 of 2797 in total